Reprogramming the future of medicine

We generate high-quality patient-specific pluripotent stem cells for research, translational medicine, and regenerative therapies.

Mission

We biobank and distribute human induced pluripotent stem cells as essential tools for the global research community. By providing robust, well-characterized hiPSC cell lines, we support scientists in building accurate patient-derived disease models, investigating pathogenic mechanisms, screening therapeutic candidates, and accelerating translational medicine programs.

From biological sample to
validated hiPSC delivery in 30 days

Day 0 – 7 | Phase 1

Reprogramming

Day 7 – 21 | Phase 2

Expansion

Day 21 – 41 | Phase 3

Biobanking

The project

A fully integrated pipeline from patient sample to certified hiPSC.

We provide a comprehensive pipeline for hiPSC research, from initial derivation to specialized training:

Primary Cell Line Derivation & Expansion
Custom establishment and expansion of donor-derived primary cell lines tailored to project specifications.
Precision hiPSC Reprogramming
A seamless somatic-to-hiPSC transition utilizing our optimized reprogramming protocols to ensure high-quality outcomes.
Biobanking & Global Distribution
Management of a robust hiPSC repository, ensuring secure storage and worldwide access to well-characterized lines for the scientific community
Differentiation Potential Assays
Standardized assays to evaluate and validate the multilineage differentiation potential of hiPSC lines.
Technical Training: RNA-Based Microfluidic Reprogramming
Specialized hands-on training in microfluidic-driven mRNA delivery, enabling laboratories to implement high-efficiency reprogramming in-house.

Services

Service reprogramming

Our cellular reprogramming service uses a patented microfluidic platform that ensures high efficiency, genomic integrity, and reproducible results.

Biobanking ihPSC

Our biobanking service guarantees the secure and certified long-term storage of generated iPSC lines.

Service Organoids

3D organoid models derived from patient-specific hiPSCs for advanced disease modelling and drug

Articles

Hip-Mode Biobank: al VIMM nasce una nuova infrastruttura per la medicina di precisione

Una nuova risorsa dedicata alla ricerca biomedica prende vita presso il VIMM – Istituto Veneto di Medicina Molecolare. È stata...

Partner